Bigbear Pharmaceutical·Medication Guide

• What Is Lenvatinib Used For

  Mechanism of ActionLenvatinib is a targeted anticancer drug that exerts antitumor effects by blocking the activity of specific proteins. It primarily ···【Read More】

  Update: 2026-03-12Source: Haiou HealthViews: 196

• A potent MEK1/2 inhibitor, selumetinib, has been granted a BTD by the FDA.

  Neurofibromatosis type 1 (NF1) is an incurable genetic disorder that typically manifests in early childhood. Its severity varies greatly and can reduc···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 228

• Koselugo Approved for Treatment of NF1-Induced Neurofibromatosis in Pediatric Patients Aged 1 Year a

  The U.S. Food and Drug Administration (FDA) approved on September 10 the oral selective MEK inhibitor Koselugo (selumetinib) in oral granule and capsu···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 218

• Koselugo, a treatment for NF1 neurofibromatosis in adults, receives FDA approval.

  On November 19, 2025, AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved its mitogen-activated protein kinase kinase ···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 219

• Is Gilteritinib Covered by Medicare/Insurance? Navigating Patient Assistance Programs

  The price of giretinib (generic name: giretinib tablets) varies depending on the region, specification, medical insurance policy, and purchase channel···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 226

• How Much Does Gilteritinib Cost Per Month? Average Prices Without Insurance

  Gilteritinib is a targeted therapy for the treatment of specific types of leukemia. Currently, the price in the domestic market is approximately 30,00···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 227

• Gilteritinib (Xospata) Cost 2026: A Complete Guide to Pricing and Savings

  Gilteritinib is an FLT3 inhibitor targeting specific gene mutations, primarily used to treat relapsed or refractory acute myeloid leukemia (AML). Its ···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 238

• Gilteritinib, a targeted drug for acute myeloid leukemia, has received conditional approval in China

  Asteras Pharmaceuticals recently announced that the National Medical Products Administration (NMPA) of China has conditionally approved XOSPATA® (gite···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 233

• Xospata has been accepted by the NMPA for the treatment of relapsed or refractory FLT3 mutation-posi

  Japanese pharmaceutical company Astellas recently announced that the NMPA of China has accepted its New Drug Application (NDA) for the targeted antica···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 229

• Xospata (gilteritinib) Drug Guide

  The U.S. Food and Drug Administration (FDA) today approved Xospata (gilteritinib) tablets for the treatment of adult patients with relapsed or refract···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 219

• What should I do if I overdose on gefitinib fumarate tablets?

  If you accidentally ingest more than the dose prescribed by your doctor, contact them immediately. You may need to be hospitalized for observation and···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 238

• When can I stop taking the medication?

  Treatment with this product should continue until the patient no longer experiences clinical benefit or develops unacceptable toxicity. Because clinic···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 229

• Should Gilteritinib be taken before or after meals?

  The medicine can be taken before or after meals. It should be swallowed whole with water and should not be broken or crushed.【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 205

• What should I do if I missed taking a dose of gefitinib fumarate tablets?

  Medication should be taken at the same time every day, with at least 12 hours between doses.If you forget to take your medication or miss the schedule···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 219

• How long does the effect of gefitinib fumarate tablets typically last?

  This medication has a relatively long duration of action in the body, taking an average of 113 hours to be half metabolized. This means that the drug ···【Read More】

  Update: 2026-03-11Source: Haiou HealthViews: 210